In the present invention, it has been studied a vaccine comprising the meningococcal conjugate more than one antigen (b) 1 and (a) D-T-Pw-HepB-Hib antigens. I have found variations and number of improvements for these vaccines. The vaccine, two components: a first component comprising the...
relates to several novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses, or as targets for the development of pharmaceutically/immunologically active compounds and cells. ...
relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into ...
A dream… to come true ??? Multi-disease combos DTaP DTaP IPV DTaP IPV Hib DTaP IPV Hib HepB DTaP IPV HepB // Hib TdaP IPV Hib HB HA HB MMR MMRV Conjugate combinations Combination vaccines a large choice ! a successful experience Multivalent combos (Influenza) (Polio) Rotavirus ...
As expected, obatoclax treatment also suppressed Hepa1c1c7 expansion (Fig. S1C) and induced higher level of cell apoptosis (Fig. S1D). Furthermore, HepG2 cell line was also used to study the effects of obatoclax on human HCC cells. The results also proved that obatoclax treatment ...
Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2006 ; 2:155 - 60; http://dx.doi.org/ 10.4161/hv.2.4.2942 ; PMID: 17012890 [Taylor & Francis Online]Kanra G, Kara A, Demiralp O, et al. Safety and immunogenicity of a new ...
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine. Vaccine 2011; 29: 6042- 6048....
4 and 6 months of age.METHODS Healthy infants were randomized to receive a combination DTPa-HepB vaccine (diphtheria and tetanus toxoids, acellular pertussis antigens and hepatitis B surface antigen), concomitantly with type b and oral poliovirus vaccines at 2, 4 and 6 months of age (Group ...
And compared with using arsenic trioxidesize or genistein alone, the combination therapy suppressed tumor growth and reduced the proliferation index in HepG2 tumor-bearing mice more efficiently [31]. Besides, AIFCM can up-regulate tumor suppressor genes, such as p53, to transcriptionally activate ...
Article suggestions will be shown in a dialog on return to ScienceDirect. Other export options Direct export About Mendeley About RefWorks Export file Format RIS (for EndNote, Reference Manager, ProCite) BibTeX Text RefWorks Direct Export Content Citation Only Citation and Abstract ...